Inovio Pharmaceuticals Inc (NASDAQ:INO)
| 2.57 Delayed Data As of 4:00pm ET |  +0.185 / +7.76%Today’s Change | 1.92 Today|||52-Week Range 5.38 | -35.75% Year-to-Date |
Latest INO News | Press Releases
No recent news for Inovio Pharmaceuticals Inc.
Today’s Trading
| Previous close | 2.38 |
| Today’s open | 2.44 |
| Day’s range | 2.42 - 2.58 |
| Volume | 856,593 |
| Average volume (3 months) | 664,811 |
| Market cap | $238.5M |
Data as of 4:00pm ET, 12/10/2019
Growth & Valuation
| Earnings growth (last year) | +2.98% |
| Earnings growth (this year) | -0.63% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -27.80% |
| P/E ratio | NM |
| Price/Sales | 12.14 |
| Price/Book | 2.67 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CRHMCRH Medical Corp | 0.00 | 0.00% |
| ISEEIveric Bio Inc | +0.19 | +3.64% |
| NLTXNeoleukin Therapeuti... | +1.68 | +26.75% |
| MNKDMannKind Corp | +0.07 | +5.74% |
Data as of 6:30pm ET, 12/10/2019
Financials
| Next reporting date | March 25, 2020 |
| EPS forecast (this quarter) | -$0.24 |
| Annual revenue (last year) | $30.5M |
| Annual profit (last year) | -$97.0M |
| Net profit margin | -318.12% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Plymouth Meeting, Pennsylvania |
Forecasts
